source
- Emerging Biotechs Can Speed Development with Tailored Global Trial Strategies, Panel SaysA panel of biotech chief medical officers and CRO executives discussed how small biotechs can accelerate clinical development by using fit-for-purpose global trial designs. They highlighted both t…
- Experts split over Huidagene’s gene-editing approach after boy’s death in Duchenne trialA young boy died while participating in Huidagene’s gene‑editing trial for Duchenne muscular dystrophy, raising serious questions about the company’s experimental strategy. STAT+ reviewed video of…